Header Logo

Connection

SUSAN BLANEY to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Antineoplastic Agents, Immunological.
SUSAN BLANEY
Connection Strength
0.527
Antineoplastic Agents, Immunological
  1. Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res. 2017 Oct 15; 23(20):6062-6069.
    View in: PubMed
    Score: 0.527
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.